Patients safety
bruising
All 180 patients were monitored for safety and tolerability. One patient in the VA group discontinued the study due to a fractured upper limb unrelated to the treatment. Four patients in SA and four patients in VA groups developed mild bruising around the acupoints/non‐acupoints, all of which were back to normal after 2 weeks of follow‐up. One patient discontinued celecoxib during the intervention period due to intolerable gastric discomfort, and no further gastric discomfort occurred after 2 weeks of follow‐up.